group
Info-Tech Research Group Publishes Framework for Better Outcomes In Healthcare
Info-Tech Research Group’s latest industry research outlines the revolutionary potential of AI to personalize healthcare and offers key strategies for integrating AI-powered precision medicine into healthcare systems. The newly published blueprint provides actionable insights that enable healthcare organizations to enhance patient care and diagnostic accuracy through advanced AI applications, thereby improving treatment outcomes in the […]
Menarini Group and Insilico Medicine sign exclusive global license agreement for …
Florence, Italy and New York (ots/PRNewswire) KAT6 is a new target in hormone-sensitive breast cancer tumors and other cancers. Overexpression of KAT6A/B is associated with poor clinical outcomes in patients with ER+/HER2- breast cancer, one of the most common subtypes. The molecule showed high preclinical activity. Insilico presented data on this new molecule at the […]
Menarini Group and Insilico Medicine sign exclusive global license agreement for …
Florence, Italy and New York (ots/PRNewswire) KAT6 is a new target in hormone-sensitive breast cancer tumors and other cancers. Overexpression of KAT6A/B is associated with poor clinical outcomes in patients with ER+/HER2- breast cancer, one of the most common subtypes. The molecule showed high preclinical activity. Insilico presented data on this new molecule at the […]
Menarini Group and Insilico Medicine enter into exclusive global license agreement for new KAT6 inhibitor for potential treatment of breast cancer and other oncology indications USA – Deutsch Italia – Italiano APAC – Traditional Chinese USA – español Latin America – español USA – English USA – English
KAT6 is a new target in hormone-sensitive breast cancer tumors and other cancers. Overexpression of KAT6A/B is associated with poor clinical outcomes in patients with ER+/HER2- breast cancer, one of the most common subtypes. The molecule showed high preclinical activity. Insilico presented data on this new molecule at the San Antonio Breast Cancer Symposium in […]